Skip to main content
. 2017 Aug 24;8(44):76516–76524. doi: 10.18632/oncotarget.20407

Figure 1. Presentation of ROP-OVA on MHC class 1 molecules.

Figure 1

(A) Recombinant overlapping peptides derived from native OVA were linked by LRMK, the target sequence of cathepsin S. SIINFEKL is the epitope presented on mouse H-2b. (B) Comparison of SIINFEKL presentation on dendritic cells after incubation of DC2.4 cells with 50 μg/ml native OVA or ROP-OVA for 13 hours. The experiment was repeated twice.